Because AOD9604 does not stimulate IGF-1 production and lacks strong GH receptor agonism, it may present a safer alternative for long-term OA treatment [1]
Should I stay at my current dose longer than four weeks
doi: 10.3389/fphar.2024.1415879 Received 11 April 2024 Accepted 20 August 2024 Published 07 October 2024 Volume 15 - 2024 Edited by Nuria Lloberas, Bellvitge University Hospital, Spain Reviewed by Shao-Yu Yang, National Taiwan University Hospital, Taiwan David Arroyo, Gregorio Maran Hospital, Spain Maria Marques, Puerta de Hierro University Hospital Majadahonda, Spain Updates Copyright 2024 Martos-Guillami, Vergara, Llorens-Cebri, Motto, Martnez-Daz, Gonalves, Garcias-Ramis, Allo-Urzainqui, Narvez, Bermejo, Muoz, Len-Romn, Ferrer-Costa, Jacobs-Cach, Vilardell-Vil and Soler
Competing Interests The authors declared that they have no conflict of interest
The brand states that this review typically happens within about 24 hours, but that's a general timeline, not a guarantee
and the table below that shows the surplus (or deficit) for all 55 countries modelled
